Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000387470

Medchemexpress LLC Mepenzolate bromide | 76-90-4 | 99.9% | 420.34 | 100 MG
SDP

Catalog No. 5000387470
Encompass_Preferred

Mepenzolate bromide is an orally administered muscarinic receptor antagonist with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. It can be used to suppress gastrointestinal hypermotility associated with irritable bowel syndrome. Mepenzolate bromide is also a GPR109A inhibitor.

  • Muscarinic receptor antagonist
  • GPR109A inhibitor
  • Exerts anti-inflammatory effect via a muscarinic receptor-independent mechanism
  • Bronchodilatory effect via a muscarinic receptor-dependent mechanism
  • Subtype-non-specific muscarinic antagonist
  • Beneficial effects in a mouse model of chronic obstructive pulmonary disease (COPD)

Catalog No. 50-003-87470 Supplier Medchemexpress LLC Supplier No. HY17585100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mepenzolate bromide is an orally administered muscarinic receptor antagonist with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. It can be used to suppress gastrointestinal hypermotility associated with irritable bowel syndrome. Mepenzolate bromide is also a GPR109A inhibitor.

  • Muscarinic receptor antagonist
  • GPR109A inhibitor
  • Exerts anti-inflammatory effect via a muscarinic receptor-independent mechanism
  • Bronchodilatory effect via a muscarinic receptor-dependent mechanism
  • Subtype-non-specific muscarinic antagonist
  • Beneficial effects in a mouse model of chronic obstructive pulmonary disease (COPD)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.